Remove Diabetes Remove Medicare Remove Reimbursement
article thumbnail

Cardiology in H1 2024

CardiacWire

GLP-1s are for CVD too – So far this year GLP-1s have gone from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming an FDA-approved and Medicare-covered option for CV event reduction.